Purple Biotech Ltd.-ADRPPBT
13F holders, Q4 2024 (December 31)13holders +3
4new positions
3sold out
$4.70avg. 13F price*
At the end of Q4 2024, 13 institutions reported holding Purple Biotech Ltd.-ADR (PPBT) in their 13F filings, up 3 from Q3 2024. 4 opened new positions and 3 sold out. The largest holders were Kingswood Wealth Advisors, LLC ($158K), Two Sigma Securities, LLC ($72K) and UBS Group AG ($51K).
- Company
- Purple Biotech Ltd.-ADR
- CUSIP
- 74638P208
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $283K |
| Exits | 3 | $877K |
All 13F filers, Q3 2024 → Q4 2024: 70,604 shares bought and 161,014 shares sold, net −90,410 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Kingswood Wealth Advisors, LLC | 0.01% | New | 33,594 | $158K |
| Two Sigma Securities, LLC | 0.01% | New | 15,374 | $72K |
| UBS Group AG | 0.00% | New | 10,783 | $51K |
| Group One Trading LLC | 0.00% | Add +42740.0% | 8,568 | $40K |
| BNP Paribas Financial Markets | 0.00% | Add +46.3% | 5,375 | $25K |
| Morgan Stanley | 0.00% | Reduce -36.5% | 5,115 | $24K |
| Rhumbline Advisers | 0.00% | New | 605 | $3K |
| Crowley Wealth Management, Inc. | 0.00% | — | 300 | $1K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -11.0% | 226 | $1K |
| Royal Bank of Canada | 0.00% | No change | 107 | $1K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 200 | $938 |
| SBI Securities Co., Ltd. | 0.00% | — | 190 | $891 |
| Global Retirement Partners, LLC | 0.00% | No change | 16 | $75 |
"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd.-ADR the manager owns.